Spectrum Pharmaceuticals Inc
SPPIDelisted Aug 1, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000831547
Spectrum Pharmaceuticals Inc was delisted on Aug 1, 2023; its insiders filed their last Form 4 on Aug 1, 2023; 78 institutions reported holding it in 13F filings for Q2 2023, worth $56.5M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Spectrum Pharmaceuticals Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 69 | 78 | +9 |
| Shares | 44.6M | 58.7M | +14.2M (+31.8%) |
| Value | $33.4M | $56.5M | +$23.0M (+68.9%) |
New holders (20)
Institutions that held Spectrum Pharmaceuticals Inc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kennedy Capital Management, Inc. | 4,881,037 | $4.69M | 0.11% |
| Ergoteles LLC | 2,329,817 | $2.24M | 0.11% |
| New York Life Investment Management LLC | 1,378,422 | $1.32M | 0.01% |
| Crystalline Management Inc. | 1,063,056 | $1.02M | 0.72% |
| HGC Investment Management Inc. | 1,045,155 | $1.00M | 0.36% |
| Beryl Capital Management LLC | 508,304 | $488.0K | 0.15% |
| Thompson Siegel & Walmsley LLC | 505,024 | $485.0K | 0.01% |
| PenderFund Capital Management Ltd. | 333,220 | $424.0K | 0.13% |
| Diametric Capital, LP | 146,061 | $140.2K | 0.06% |
| XTX Topco Ltd | 144,593 | $138.8K | 0.02% |
| Qube Research & Technologies Ltd | 64,122 | $61.6K | 0.00% |
| GTS Securities LLC | 51,109 | $49.1K | 0.00% |
| Prelude Capital Management, LLC | 46,889 | $45.0K | 0.00% |
| Prudential Financial Inc | 45,200 | $43.4K | 0.00% |
| Arrowstreet Capital, Limited Partnership | 42,193 | $41.0K | 0.00% |
| Lido Advisors, LLC | 15,000 | $14.4K | 0.00% |
| CM Wealth Advisors LLC | 13,890 | $14.3K | 0.00% |
| Simplex Trading, LLC | 12,547 | $12.0K | 0.00% |
| Rhumbline Advisers | 3,600 | $3.46K | 0.00% |
| Citadel Advisors LLC | 100 | $96 | 0.00% |
Sold out (11)
Institutions that held Spectrum Pharmaceuticals Inc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Ikarian Capital, LLC | 176,980 | $132.7K |
| Bridgeway Capital Management, LLC | 150,000 | $112.5K |
| Winton Group Ltd | 109,140 | $81.9K |
| Boothbay Fund Management, LLC | 30,401 | $22.8K |
| Two Sigma Securities, LLC | 24,553 | $18.4K |
| ExodusPoint Capital Management, LP | 24,300 | $18.0K |
| West Michigan Advisors, LLC | 17,000 | $12.8K |
| Moors & Cabot, Inc. | 12,400 | $9.30K |
| Independent Advisor Alliance | 10,800 | $8.10K |
| Kalos Management, Inc. | 200 | $150 |
| TCI Wealth Advisors, Inc. | 100 | $75 |